Corient IA’s West Pharmaceutical WST Stock Holding History

Corient IA’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,795	Closed	-$393K	–	288
2025 Q2	$393K	Hold	1,795	–	–	0.23%	171
2025 Q1	$402K	Buy	+1,795	New	+$495K	0.29%	136

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Corient IA's WST Position: Q3 2025 in Review

Corient IA sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 1,795 shares — an estimated $393K sold.

Corient IA first reported a position in WST in Q1 2025 and held it in 2 quarters. The position peaked at $402K in Q1 2025. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

Corient IA reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
Corient IA sold 1,795 West Pharmaceutical shares in Q3 2025, an estimated $393K.
Corient IA first reported a position in West Pharmaceutical in Q1 2025 and held it in 2 quarters.
Corient IA's West Pharmaceutical position peaked at $402K in Q1 2025.
756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Corient IA's 13F filing for Q3 2025, filed 12 Nov 2025.